Gynecologic Cancers and Non-Coding Rnas: Epigenetic Regulators With Emerging Roles Publisher Pubmed



Razavi ZS¹ ; Tajiknia V² ; Majidi S³ ; Ghandali M⁴ ; Mirzaei HR⁵ ; Rahimian N⁶ ; Hamblin MR^{7, 8, 9} ; Mirzaei H¹⁰
Source: Critical Reviews in Oncology/Hematology Published:2021

Abstract

Gynecologic cancers involve the female genital organs, such as the vulva, vagina, cervix, endometrium, ovaries, and fallopian tubes. The occurrence and frequency of gynecologic cancer depends on personal lifestyle, history of exposure to viruses or carcinogens, genetics, body shape, and geographical habitat. For a long time, research into the molecular biology of cancer was broadly restricted to protein-coding genes. Recently it has been realized that non-coding RNAs (ncRNA), including long noncoding RNAs (LncRNAs), microRNAs, circular RNAs and piRNAs (PIWI-interacting RNAs), can all play a role in the regulation of cellular function within gynecological cancer. It is now known that ncRNAs are able to play dual roles, i.e. can exert both oncogenic or tumor suppressive functions in gynecological cancer. Moreover, several clinical trials are underway looking at the biomarker and therapeutic roles of ncRNAs. These efforts may provide a new horizon for the diagnosis and treatment of gynecological cancer. Herein, we summarize some of the ncRNAs that have been shown to be important in gynecological cancers. © 2020 Elsevier B.V.